Home / Health / ADHD Patients Face Medication Cost Crisis
ADHD Patients Face Medication Cost Crisis
9 Dec, 2025
Summary
- Patients with private ADHD diagnoses struggle with high medication costs.
- One father faces approximately £1,500 annually for medication and assessments.
- GPs can refuse NHS prescriptions for shared care agreements due to capacity.
Individuals diagnosed with ADHD privately are confronting substantial out-of-pocket expenses for necessary medications and ongoing assessments. One father's experience underscores this challenge, with annual costs reaching approximately £1,500. His attempt to secure an NHS prescription was unsuccessful, leading to calls for improved patient treatment and support.
This financial strain arises because GPs can opt out of shared care agreements, a system designed to integrate private specialist care with NHS prescriptions. Such refusals are permitted if healthcare providers deem they lack the capacity to ensure safe and effective patient management.
The government acknowledges this flexibility for GPs, emphasizing that patient safety remains paramount. However, the current system creates significant barriers for those seeking affordable ADHD treatment, prompting concerns about equitable access to care.
